Companies: 10,795·Total market cap: $144.5T
MedinCell S.A.

MedinCell S.A.

MDCLFOTCHealthcare● Active
$34.39
+$0.00(+0.00%)
Market Cap$1.2B
P/E Ratio—
52W High$34.39
52W Low$6.9757
Cash on HandFinancialsRevenue

MedinCell S.A. (MDCLF) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

MDCLF · cash on hand · updated Mar 31, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$71.9M▲ +269.5% vs prior year
FY · as of Mar 31, 2025 · Reported in EUR
Cash & Cash Equiv. (CCE)
$59.0M
cashAndCashEquivalents
Short-Term Investments
$12.9M
shortTermInvestments
YoY Change vs Prior Year
+269.5%
vs prior fiscal year
Latest Quarter
$53.6M
Q3 2025
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in EUR

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: March 31, 2025

Net cash vs debt

Cash & ST Investments$71.9MCash on Hand
Total Debt$58.8MTotal Debt
Net Cash / Net Debt+$13.1MNet Cash Position
Cash vs Debt Ratio
Cash 55%Debt 45%

MedinCell S.A. has a net cash position of $13.1M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$71.9M − $58.8M = +$13.1M

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
MDCLF annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Mar 31, 2025Latest$71.9M+269.5%
Mar 31, 2024$19.5M+200.9%
Mar 31, 2023$6.5M-75.7%
Mar 31, 2022$26.6M-46.7%
Mar 31, 2021$49.9M+302.9%
MDCLF cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.6%#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
MedinCell S.A.
MedinCell S.A.YOU
MDCLF
$71.9M5.8%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

MedinCell S.A. (MDCLF) cash on hand as of March 31, 2025 is $71.9M, comprising $59.0M in cash and cash equivalents (CCE) plus $12.9M in short-term investments — reported as MedinCell S.A. cash and short-term investments on the balance sheet (10-K filing). Also referred to as MedinCell S.A. cash reserves or cash position.

MedinCell S.A. annual cash on hand history shows increased +269.5% in 2025: increased +269.5% in 2025. MedinCell S.A. cash reserves in 2025 reflect the company's capital allocation strategy.

MedinCell S.A. carries total debt of $58.8M against cash of $71.9M, resulting in a net cash position of +$13.1M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.
Financial statementsFree cash flowNet incomeRevenueMarket capP/E ratioEarningsPrice history

Frequently asked questions

MDCLF cash on hand · 5 questions

As of March 31, 2025, MedinCell S.A. (MDCLF) has $71,897,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $59,040,000 in cash and cash equivalents (CCE) plus $12,857,000 in short-term investments. Latest quarter (September 30, 2025): $53,602,000. Data sourced from the annual 10-K filing via FMP.

MDCLF cash on handMDCLF cash reservesMDCLF cash 2025how much cash does MDCLF have

▸ Source: FMP /balance-sheet-statement · US GAAP · MedinCell S.A. · MedinCell S.A. SEC 10-K & 10-Q filings · US GAAP · Last updated: March 31, 2025